CAS: 781613-23-8 - N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-{[(3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy}-4-quinazolinamine
Formula:C24H25Cl2FN4O2
InChI:InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13?,14-,15+
- Synonyms:
- Xl647
- 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aa,5a,6aa)-octahydro- 2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-
- Xl 647
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
XL647 REF: AN-AG00G3QJCAS: 781613-23-8 | 98% | 97.00 €~527.00 € | Thu 09 May 24 | |
Tesevatinib REF: TM-TQ0166CAS: 781613-23-8 | 97.89% | 106.00 €~1,003.00 € | Thu 16 May 24 | |
XL 647 REF: 3D-FX103992CAS: 781613-23-8 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG00G3QJ
1mg | 97.00 € | |
2mg | 118.00 € | |
10mg | 281.00 € | |
25mg | 527.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Tesevatinib
CAS:781613-23-8
Tesevatinib (XL-647) is an orally available, multi-target tyrosine kinase inhibitor (IC50s: 0.3, 16, 1.5, 8.7, …
Formula:
C24H25Cl2FN4O2
Purity:
97.89%
Color and Shape:
Solid
Molecular weight:
491.39
Ref: TM-TQ0166
1mg | 106.00 € | |
2mg | 152.00 € | |
5mg | 232.00 € | |
10mg | 450.00 € | |
25mg | 737.00 € | |
50mg | 1,003.00 € | |
1ml*10 (DMSO) | 250.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
XL 647
CAS:781613-23-8
Inhibitor of EGFR, HER2 and VEGFR2 tyrosine kinases
Formula:
C24H25Cl2FN4O2
Purity:
Min. 95%
Molecular weight:
491.38 g/mol
Ref: 3D-FX103992
50mg | To inquire | |
100mg | To inquire | |
250mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024